NanoEcho AB (publ) (STO:NANECH)

Sweden flag Sweden · Delayed Price · Currency is SEK
0.0443
+0.0003 (0.68%)
At close: Mar 6, 2026
-72.62%
Market Cap 12.22M
Revenue (ttm) 487.00K
Net Income (ttm) -15.65M
Shares Out 292.94M
EPS (ttm) -0.06
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 557,190
Average Volume 1,658,067
Open 0.0450
Previous Close 0.0440
Day's Range 0.0400 - 0.0450
52-Week Range 0.0390 - 0.1898
Beta n/a
RSI 39.39
Earnings Date Feb 12, 2026

About NanoEcho AB

NanoEcho AB (publ) engages in developing diagnostic method to investigate the spread of rectal cancer to nearby lymph nodes. The company was incorporated in 2013 and is based in Lund, Sweden. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2013
Employees 6
Stock Exchange Nasdaq Stockholm
Ticker Symbol NANECH
Full Company Profile

Financial Performance

In 2025, NanoEcho AB's revenue was 487,000, a decrease of -93.30% compared to the previous year's 7.27 million. Losses were -15.65 million, 3.35% more than in 2024.

Financial Statements

News

There is no news available yet.